NCT05524935 2026-01-08Olaparib in Combination With Pembrolizumab for Advanced Uveal MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Recruiting37 enrolled
NCT04130516 2025-12-18Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With PembrolizumabLinnaeus Therapeutics, Inc.Phase 1/2 Recruiting200 enrolled